Uncategorised Archives - Page 25 of 34

Sickle Cell Disease Treatment Pipeline: Detailed 2026 Insights

DelveInsight’s “Sickle Cell Disease Pipeline Insights 2026” analysis delivers extensive perspectives on 55+ organizations and 60+ therapeutic candidates in the Sickle Cell Disease Competitive environment. It encompasses Sickle Cell Disease Pipeline Treatment evaluation by product classification, developmental phase, administration route, and molecular

8 April 2026

Uncategorised

Alzheimer’s Disease Market Insight, Epidemiology And Market Forecast 2034

DelveInsight’s “Alzheimer’s Disease Market Insights, Epidemiology, and Market Forecast 2034” offers an in-depth exploration of the complex landscape of Alzheimer’s Disease (AD) across the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan. The report delivers a robust

8 April 2026

Uncategorised

KRAS Inhibitors Market Poised for Explosive Growth: Projected to Surge from USD 526 Million in 2025 to USD 7,847 Million by 2034

KRAS Inhibitors Market Summary The KRAS Inhibitors market is on the cusp of a transformative decade, driven by unprecedented scientific breakthroughs, regulatory milestones, and a rapidly expanding pipeline of targeted oncology therapies. Valued at approximately USD 526 million across the Seven Major

8 April 2026

Uncategorised

Heparin-induced Thrombocytopenia Market Analysis, Epidemiology Forecast, and Treatment Landscape Through 2032

DelveInsight’s comprehensive analysis titled “Heparin-induced Thrombocytopenia Market Insights, Epidemiology, and Market Forecast-2032” offers detailed intelligence on Heparin-induced Thrombocytopenia, encompassing historical and projected epidemiological data alongside Heparin-induced Thrombocytopenia market dynamics across the United States, EU5 nations (Germany, Spain, Italy, France, and United Kingdom),

8 April 2026

Uncategorised

Congenital Adrenal Hyperplasia Drugs Market 2034: Emerging Therapies, Clinical Trials, and Key Players

(Albany, USA) – DelveInsight’s “Congenital Adrenal Hyperplasia Market Insights, Epidemiology, and Market Forecast – 2034” provides a comprehensive analysis of the CAH landscape, covering current treatment practices, emerging therapies, market share of individual drugs, and projected market size from 2020 to 2034

8 April 2026

Uncategorised

Alopecia Areata Market: Emerging Therapies, Epidemiology, and Growth Forecast 2026–2036 Across Seven Major Markets

Alopecia Areata Market The alopecia areata market is poised for steady growth, with a strong compound annual growth rate (CAGR) projected from 2026 to 2036. This expansion across the 7MM will be driven by the launch of innovative therapies, including RINVOQ (upadacitinib),

7 April 2026

Uncategorised

SGLT2 Inhibitor Market Size in the 7MM is projected to grow at a significant CAGR by 2034, estimates DelveInsight

DelveInsight’s “SGLT2 Inhibitors Market Size, Target Population, Competitive Landscape, and Market Forecast – 2034” report delivers an in-depth understanding of the SGLT2 Inhibitor, historical and Competitive Landscape as well as the SGLT2 Inhibitors market trends in the United States, EU4 (Germany, France,

7 April 2026

Uncategorised

CLK Inhibitors Market Size in the 7MM is projected to grow at a significant CAGR by 2034, estimates DelveInsight

DelveInsight’s “CLK Inhibitors Market Size, Target Population, Competitive Landscape, and Market Forecast – 2034” report delivers an in-depth understanding of the CLK Inhibitor, historical and Competitive Landscape as well as the CLK Inhibitors market trends in the United States, EU4 (Germany, France,

7 April 2026

Uncategorised

Hepatic Cirrhosis: Comprehensive Market Intelligence, Epidemiology, and Forecast Analysis Through 2032

DelveInsight’s “Hepatic Cirrhosis Market Insights, Epidemiology, and Market Forecast-2032” analysis provides comprehensive understanding of Hepatic Cirrhosis, encompassing historical and projected epidemiology alongside market trajectories across the United States, EU5 nations (Germany, Spain, Italy, France, and United Kingdom), and Japan. Download analysis @https://www.delveinsight.com/report-store/hepatic-cirrhosis-market?utm_source=pngw&utm_medium=pr&utm_campaign=kkpr

7 April 2026

Uncategorised

Acute Kidney Injury Market: Epidemiology, Therapies, Companies, DelveInsight

Acute Kidney Injury Market, DelveInsight Acute Kidney Injury therapies such as RBT-1, OCE-205, and other emerging candidates are anticipated to contribute significantly to the expansion of the Acute Kidney Injury Market in the coming years. DelveInsight has released a new report titled

6 April 2026

Uncategorised - Page 25

Tourette Syndrome Pipeline 2026: Investigational Therapies, Clinical Trial Advances, and Key Regulatory Developments by DelveInsight

Sickle Cell Disease Treatment Pipeline: Detailed 2026 Insights

Alzheimer’s Disease Market Insight, Epidemiology And Market Forecast 2034

KRAS Inhibitors Market Poised for Explosive Growth: Projected to Surge from USD 526 Million in 2025 to USD 7,847 Million by 2034

Heparin-induced Thrombocytopenia Market Analysis, Epidemiology Forecast, and Treatment Landscape Through 2032

Congenital Adrenal Hyperplasia Drugs Market 2034: Emerging Therapies, Clinical Trials, and Key Players

Alopecia Areata Market: Emerging Therapies, Epidemiology, and Growth Forecast 2026–2036 Across Seven Major Markets

SGLT2 Inhibitor Market Size in the 7MM is projected to grow at a significant CAGR by 2034, estimates DelveInsight

CLK Inhibitors Market Size in the 7MM is projected to grow at a significant CAGR by 2034, estimates DelveInsight

Hepatic Cirrhosis: Comprehensive Market Intelligence, Epidemiology, and Forecast Analysis Through 2032

Acute Kidney Injury Market: Epidemiology, Therapies, Companies, DelveInsight

Recent Posts

Banner

Newsletter

Authors

pharmaglobenews

Michael Ashford

NCFB Market on the Brink of Change as First DPP1 Inhibitor Marks Approval | DelveInsight

Suggestions

Uncategorised - Page 25

Recent Posts

Banner

Newsletter

Authors